Related Experiment Videos
'Progressive' versus 'indolent' idiopathic membranous glomerulonephritis
J M Bone1, R Rustom, P S Williams
1Regional Renal Unit, Royal Liverpool University Hospital.
QJM : Monthly Journal of the Association of Physicians
|February 25, 1998
Summary
Idiopathic membranous glomerulonephritis (MGN) management varies. Observation is effective for indolent cases, while progressive MGN patients responded well to delayed immunosuppressive therapy, improving renal outcomes.
Area of Science:
- Nephrology
- Internal Medicine
Background:
- Idiopathic membranous glomerulonephritis (MGN) lacks universally agreed-upon treatment guidelines.
- Clinical observation and aggressive immunosuppression represent distinct therapeutic approaches.
Purpose of the Study:
- To evaluate the long-term outcomes of conservative versus aggressive treatment strategies for idiopathic membranous glomerulonephritis (MGN).
Main Methods:
- A retrospective analysis of 63 idiopathic MGN patients over 20 years.
- Classification into 'progressive' (requiring intervention) and 'indolent' (observation only) groups.
- Comparison of renal function, proteinuria, and survival rates between groups.
Main Results:
- Progressive MGN patients treated with steroids and azathioprine showed prompt response and improved renal survival.
- Indolent MGN patients remained stable with symptomatic treatment; many experienced proteinuria remission.
- Delayed treatment in progressive MGN still led to favorable outcomes, with dialysis delayed in several cases.
Conclusions:
- Conservative management is effective for indolent idiopathic MGN.
- Delayed, but prompt, immunosuppressive therapy can significantly improve outcomes in progressive idiopathic MGN.
- Long-term survival is achievable with appropriate management strategies for idiopathic MGN.